In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Getinge/Maquet CV Emerging As Mid-Cap Strategic With Atrium Acquisition

Executive Summary

At a time when the cardiovascular device industry is seeing less interest in M&A on the part of several large strategic players that formerly were major acquirers, a new mid-cap player appears to be emerging: Getinge's Maquet Cardiovascular division. The company recently announced its third major cardiovascular deal in the last five years with its $680 million acquisition of Hudson, NH-based Atrium Medical, which has a diversified cardiovascular products business.

Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts